Class 4 Medicines Defect Information: Omega Pharma Limited, Niquitin 14mg Clear Patch (14 patches), EL(22)A/32
Omega Pharma Limited have identified an error relating to the product packaging.
MDR Number
MDR 041-07/22
Company name
Omega Pharma Limited
Product description
Niquitin 14mg Clear Patch PL 02855/0251
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 0370102 | Aug-2024 | 14 patches | 08-Jun-2022 |
| 1110101 | Mar-2025 | 14 patches | Not Distributed Yet |
Active Pharmaceutical Ingredient: Nicotine
Brief description of the problem
Omega Pharma Limited have identified an error relating to the product packaging. In the ‘Ingredients’ section on the base of the carton, the patch dosage is stated as providing 21mg of nicotine per day. The correct dosage is 14mg per day. The other dosage indications on the carton, the sachets, PIL and SmPC are correct. There is no issue with the product quality and the batch is not being recalled.
Advice for healthcare professionals and retailers
Healthcare professionals and other retailers are advised to note the error relating to the product packaging and where possible should refer to the dose on the other areas of the carton or sachet which remains correct. As stated above, each patch provides 14mg of nicotine per day and this information should be used when using this product.
Since all batches are within specification and there are no quality issues with the product, the batches on hold awaiting distribution will be sold and have been included in this notification for information. Omega Pharma Limited have confirmed that only these two batches are impacted and all future batches will be packaged with the correct carton.
Advice for patients
Patients are advised to note the error relating to the product packaging and are not required to take any further action at this time. The medicine itself is not affected and each patch provides 14mg of nicotine per day. If you have concerns about a medicine you may be using, please contact your healthcare professional.
Further Information
For medical information and stock control queries please contact: uklocustomerservice@perrigo.com
Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Yours faithfully
Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574
Download document